Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
An Opsonic Phagocytosis Assay for Plasmodium falciparum SporozoitesClinical and vaccine immunology, 2017-02, Vol.24 (2) [Peer Reviewed Journal]Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 1556-6811 ;EISSN: 1556-679X ;DOI: 10.1128/CVI.00445-16 ;PMID: 27881488Full text available |
|
2 |
Material Type: Article
|
Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized micenpj vaccines, 2017-10, Vol.2 (1), p.27-27, Article 27 [Peer Reviewed Journal]The Author(s) 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-017-0028-2 ;PMID: 29263882Full text available |
|
3 |
Material Type: Article
|
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingCell, 2020-09, Vol.182 (5), p.1295-1310.e20 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 The Author(s) 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.012 ;PMID: 32841599Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responsesCell, 2022-03, Vol.185 (5), p.872-880.e3 [Peer Reviewed Journal]2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2022.01.011 ;PMID: 35123650Full text available |
|
5 |
Material Type: Article
|
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based DesignFrontiers in immunology, 2021-06, Vol.12 [Peer Reviewed Journal]Copyright © 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King 2021 Ellis, Brunette, Crawford, Walls, Pham, Chen, Herpoldt, Fiala, Murphy, Pettie, Kraft, Malone, Navarro, Ogohara, Kepl, Ravichandran, Sydeman, Ahlrichs, Johnson, Blackstone, Carter, Starr, Greaney, Lee, Veesler, Bloom and King ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.710263 ;PMID: 34267764Full text available |
|
6 |
Material Type: Article
|
PfCap380 as a marker for Plasmodium falciparum oocyst development in vivo and in vitroMalaria journal, 2018-04, Vol.17 (1), p.135-135, Article 135 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s) 2018 ;ISSN: 1475-2875 ;EISSN: 1475-2875 ;DOI: 10.1186/s12936-018-2277-6 ;PMID: 29609625Full text available |
|
7 |
Material Type: Article
|
Assessing drug efficacy against Plasmodium falciparum liver stages in vivoJCI insight, 2018-01, Vol.3 (1) [Peer Reviewed Journal]Copyright © 2018, American Society for Clinical Investigation 2018 American Society for Clinical Investigation ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.92587 ;PMID: 29321371Full text available |
|
8 |
Material Type: Article
|
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesCell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077Full text available |
|
10 |
Material Type: Article
|
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429bioRxiv, 2021-042021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.03.31.437925v1 ;DOI: 10.1101/2021.03.31.437925Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and miceCell Reports, 2022-08, Vol.40 (9), p.111299-111299, Article 111299 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Author(s) 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.111299 ;PMID: 35988541Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityNature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199Full text available |
|
13 |
Material Type: Article
|
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 bindingbioRxiv, 2020-062020. This article is published under http://creativecommons.org/licenses/by/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.06.17.157982Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesbioRxiv, 2021-032021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesbioRxiv, 2021-022021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2bioRxiv, 2020-082020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395Digital Resources/Online E-Resources |